The SurePulse exhibition booth at the recent PAS (Pediatric Academic Societies) meeting in Denver, Colorado generated great excitement. Neonatologists from around the world gathered to learn more about SurePulse’s new technology that has the potential to improve the life chances for newborn babies, in particular those born premature or in a poor condition.
SurePulse is dedicated to developing vital signs monitoring solutions that make a difference to the care of newborn babies; their first device, the SurePulse VS, is a wireless heart rate monitor specifically designed around the needs of the newborn babies and the clinical teams supporting birth. SurePulse VS received FDA 510(k) clearance in 2021 and many of the visitors to the PAS exhibition booth expressed an interest in adopting the new technology into their own clinical practice.